HOUSTON, TX--(Marketwired - Jun 18, 2013) - Idera, a leading provider of application and server management solutions, today announced that VCE, a leading converged cloud infrastructure systems ...

LAS VEGAS, NV--(Marketwired - May 16, 2013) - In booth 17 at the Lifeboat Partner Summit West, Idera, a leading provider of application and server management solutions, announced that the Company ...

Idera, a provider of management and administration solutions for Microsoft Windows Servers, has announced the latest version of SQL diagnostic manager, 6.0. The tool is a SQL Server performance and ...

HOUSTON—May 23, 2019—Idera, Inc. (“Idera” or “the Company”), parent company of global B2B software productivity brands, today announced it will receive a new minority investment from Partners Group, a ...

Partners Group has taken a controlling stake in Idera in a transaction that values the business-to-business software company at close to $3 billion, sources familiar with the deal’s terms told PE Hub.

Shares of Idera Pharmaceuticals (NASDAQ: IDRA) are down around 15% year to date. And that's a good thing, relatively speaking: The clinical-stage biotech's stock was down by more than 55% just a few ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Nov 18, 2021 at ...

Travis CI, the popular Berlin-based open-source continuous integration service, has been acquired by Idera, a company that offers a number of SQL database management and administration tools for both ...

Our team tests, rates, and reviews more than 1,500 products each year to help you make better buying decisions and get more from technology. Idera Uptime Infrastructure Monitor gets a lot of things ...

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biotechnology company developing novel therapeutics for orphan patient populations with B-cell lymphomas and autoimmune diseases, announced ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that data from its Phase 1 clinical trial of IMO-2125, its novel immune modulator for the treatment of ...

EXTON, Pa., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA; “Idera”) today announced that Daniel Soland will join Idera on January 4, 2021, as Senior Vice President and ...